entrinsic bioscience

Entrinsic Bioscience is a private, U.S.-based biotech firm founded in 2009, focused on translating amino acid science into functional ingredients and active pharmaceutical ingredients (APIs). Its core asset is a patented discovery platform that maps and validates specific amino acid combinations to selectively modulate proteins, aiming to enhance quality of life across several therapeutic areas. The company operates a platform and partnership business model, working with global partners to commercialize formulations for the self-care and health product markets, positioning itself at the intersection of nutrition, wellness, and targeted therapeutics.

Proprietary biomapping and electrophysiology platform that identifies, targets, and validates combinations of amino acids as functional ingredients and APIs to selectively modulate protein regulation and cell signaling.

Entrinsic competes in the crowded functional ingredient and nutraceutical space, but differentiates itself through its patented platform and extensive IP covering specific amino acid combinations. Competitors range from large ingredient suppliers (e.g., DSM, Kerry) to biotechs focused on microbiome or peptide therapeutics.